News / Events

Press Releases

Immudyne Announces Definitive Endorsement Agreement with Leading Dermatologist

MT. KISCO, N.Y., Dec. 07, 2016 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC health and wellness  products addressing large unmet needs, today announced  that a Definitive Agreement has been reached with Dr. Lilliana Ramirez to endorse and assist with the development of a new line of skincare products based on Immudyne’s proprietary Yeast Beta Glucan ingredient. The brand, Inate MD, will be launched nationally January 1, 2017.

Dr. Lilliana Ramirez is a practicing, board certified dermatologist with a distinguished track record in medicine and academics.  She graduated Magna Cum Laude from the University of Puerto Rico and has received many awards for both her research and the practice of medicine. 

“Immudyne is partnering with and associating our brand with yet another highly accomplished dermatologist,” stated Mark McLaughlin, President and CEO of Immudyne.

“I’m very pleased to be working with Immudyne,” said Dr. Ramirez.  "The Inate MD skincare line is backed by excellent science and a great management team.  I think my patients and consumers across the county will enjoy and benefit from use of the Inate MD product line.”

The Inate MD line will initially be available exclusively online and will consist of a Serum, Moisturizer, Instant Wrinkle Eraser and an optional nutritional supplement to support healthier skin and the human Immune System.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which are, in some cases, beyond the control of Immudyne. Actual events, performance or results could differ materially from the anticipated events, performance or results expressed or implied by such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

About ImmuDyne, Inc.

lmmuDyne, Inc. (the "Company") is a health and wellness company which develops, manufactures, markets, and sells innovative lifestyle products. The Company's lead products contain its proprietary yeast beta glucans that have been shown through testing and analysis to support the immune system. ImmuDyne also has a majority owned direct marketing division that markets immune support, skincare and hair loss products directly to consumers around the world. All of the Company’s intellectual property is protected by patents and/or trade secrets. Additional information can be found on the web at

lmmuDyne, Inc.
Mark McLaughlin: +1-914-714-8901

Source: ImmuDyne, Inc.